Frankfurt - Delayed Quote EUR
Xenon Pharmaceuticals Inc. (XP0.F)
26.20
-0.20
(-0.76%)
At close: 8:02:54 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-196,854
-181,389
-151,112
-101,028
-69,502
Investing Cash Flow
242,703
165,000
-111,385
-293,405
-246,770
Financing Cash Flow
13,281
12,130
353,522
278,471
447,543
End Cash Position
118,026
142,712
148,643
57,242
175,688
Interest Paid Supplemental Data
--
--
--
0
0
Capital Expenditure
-2,930
-3,075
-5,617
-2,894
-2,050
Issuance of Capital Stock
--
12,083
353,487
277,766
447,283
Repayment of Debt
--
--
--
0
0
Free Cash Flow
-199,784
-184,464
-156,729
-103,922
-71,552
12/31/2021 - 12/4/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4DN.F Denali Therapeutics Inc.
12.54
+1.42%
WXXWY WuXi Biologics (Cayman) Inc.
5.99
+0.67%
ADAG Adagene Inc.
1.7700
-2.75%
VIGL Vigil Neuroscience, Inc.
2.4900
+7.33%
BLTE Belite Bio, Inc
64.40
-3.98%
BCDA BioCardia, Inc.
2.4400
+5.17%
2269.HK WuXi Biologics (Cayman) Inc.
23.550
-1.26%
KYMR Kymera Therapeutics, Inc.
30.25
+0.77%
RCUS Arcus Biosciences, Inc.
8.56
-0.12%
CLSD Clearside Biomedical, Inc.
0.8789
+1.67%